Bầu cử sớm tại Áo: Đảng ÖVP của cựu Thủ tướng Sebastian Kurz dẫn đầu

Ngày 29/9, khoảng 6,4 triệu cử tri Áo đã tham gia cuộc bầu cử quốc hội trước thời hạn, sau sự tan vỡ của liên minh bảo thủ cánh hữu của Đảng Nhân dân Áo (ÖVP) và Đảng Tự do (FPÖ) hồi tháng 5/2019 bởi vụ bê bối Ibizagate liên quan tới Phó Thủ tướng Heinz-Christian Strache kiêm lãnh đạo của đảng FPÖ.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh